Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In studies, patients taking semaglutide lost more weight compared to those not on the medication
Then the larger TriNetX analysis presented at ACR 2025 more than 12,000 semaglutide users, propensity-matched showed lower risk of stiffness, swelling, pain, and synovitis at 30 days, 3 months, and a year
In the SURMOUNT-5 trial (comparing these drugs at weight-loss doses), more people discontinued semaglutide due to side effects (5.6%) than tirzepatide (2.7%)
Prescription Alternatives to Semaglutide Semaglutide isn't the only GLP-1 on the market
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis
